Skinvisible SKVI
OTC SKVI
$0.20 -0.23 (-53.49%)
At close: Sep 4, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Operating Expenses (2010 - 2026)

Skinvisible's (SKVI) quarterly Operating Expenses came in at $117817.0 in Q2 2026, down 16.58% year-over-year from $141237.0 in Q2 2025, and down 10.02% quarter-over-quarter from $130938.0 in Q1 2026.

Analysis

Skinvisible (SKVI) Operating Expenses (2010 - 2026) Analysis & Trends

Skinvisible has disclosed Operating Expenses across 17 years of filings, most recently posting $117817.0 for Q2 2026.

  • In Q2 2026, Operating Expenses fell 16.58% year-over-year to $117817.0; the TTM figure through Jun 2026 stood at $478981.0 (down 22.72% YoY), while the FY2025 annual figure was $516315.0, down 15.3% from the prior year.
  • Operating Expenses came in at $117817.0 for Q2 2026 at Skinvisible, down from $130938.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $203743.0 in Q4 2024 to a low of $111057.0 in Q3 2025.
  • Average Operating Expenses over 5 years is $133219.7, with a median of $130453.5 recorded in 2024.
  • Year-over-year, Operating Expenses surged 43.95% in 2024 and plunged 41.51% in 2025.
  • Over 5 years, Operating Expenses stood at $122716.0 in 2022, then grew by 15.34% to $141538.0 in 2023, then surged by 43.95% to $203743.0 in 2024, then tumbled by 41.51% to $119169.0 in 2025, then dropped by 1.13% to $117817.0 in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $117817.0 in Q2 2026, $130938.0 in Q1 2026, and $119169.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 10.12 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 10.56 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -6.09 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 6.68 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -5.98 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 505.13 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 976.14 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 452.50 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 117,817.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117,817.00
Mar 31, 2026 130,938.00
Dec 31, 2025 119,169.00
Sep 30, 2025 111,057.00
Jun 30, 2025 141,237.00
Mar 31, 2025 144,852.00
Dec 31, 2024 203,743.00
Sep 30, 2024 129,969.00
Jun 30, 2024 147,693.00
Mar 31, 2024 128,184.00
Dec 31, 2023 141,538.00
Sep 30, 2023 118,110.00
Jun 30, 2023 117,823.00
Mar 31, 2023 132,904.00
Dec 31, 2022 122,716.00
Sep 30, 2022 133,183.00
Jun 30, 2022 119,010.00
Mar 31, 2022 138,011.00
Dec 31, 2021 105,315.00
Sep 30, 2021 119,274.00